Novel “ruthenium cyclopentadienyl”–peptide conjugate complexes against human FGFR(+) breast cancer

2020 ◽  
Vol 49 (18) ◽  
pp. 5974-5987
Author(s):  
João Franco Machado ◽  
Miguel Machuqueiro ◽  
Fernanda Marques ◽  
M. Paula Robalo ◽  
M. Fátima M. Piedade ◽  
...  

Synthesis of the first half-sandwich ruthenium(ii)-cyclopentadienyl peptide conjugates and their biological evaluation against human FGFR(+) and FGFR(−) breast cancer cells.

2021 ◽  
Vol 14 (2) ◽  
pp. 169
Author(s):  
Gloria Ana ◽  
Patrick M. Kelly ◽  
Azizah M. Malebari ◽  
Sara Noorani ◽  
Seema M. Nathwani ◽  
...  

We report the synthesis and biochemical evaluation of compounds that are designed as hybrids of the microtubule targeting benzophenone phenstatin and the aromatase inhibitor letrozole. A preliminary screening in estrogen receptor (ER)-positive MCF-7 breast cancer cells identified 5-((2H-1,2,3-triazol-1-yl)(3,4,5-trimethoxyphenyl)methyl)-2-methoxyphenol 24 as a potent antiproliferative compound with an IC50 value of 52 nM in MCF-7 breast cancer cells (ER+/PR+) and 74 nM in triple-negative MDA-MB-231 breast cancer cells. The compounds demonstrated significant G2/M phase cell cycle arrest and induction of apoptosis in the MCF-7 cell line, inhibited tubulin polymerisation, and were selective for cancer cells when evaluated in non-tumorigenic MCF-10A breast cells. The immunofluorescence staining of MCF-7 cells confirmed that the compounds targeted tubulin and induced multinucleation, which is a recognised sign of mitotic catastrophe. Computational docking studies of compounds 19e, 21l, and 24 in the colchicine binding site of tubulin indicated potential binding conformations for the compounds. Compounds 19e and 21l were also shown to selectively inhibit aromatase. These compounds are promising candidates for development as antiproliferative, aromatase inhibitory, and microtubule-disrupting agents for breast cancer.


Molecules ◽  
2021 ◽  
Vol 26 (19) ◽  
pp. 5745
Author(s):  
Murat Bingul ◽  
Greg M. Arndt ◽  
Glenn M. Marshall ◽  
David StC. Black ◽  
Belamy B. Cheung ◽  
...  

The dihydropyranoindole structures were previously identified as promising scaffolds for improving the anti-cancer activity of histone deacetylase inhibitors. This work describes the synthesis of related furoindoles and their ability to synergize with suberoylanilide hydroxamic acid (SAHA) against neuroblastoma and breast cancer cells. The nucleophilic substitution of hydroxyindole methyl esters with α-haloketones yielded the corresponding arylether ketones, which were subsequently cyclized to tricyclic and tetracyclic furoindoles. The furoindoles showed promising individual cytotoxic efficiency against breast cancer cells, as well as decent SAHA enhancement against cancer cells in select cases. Interestingly, the best IC50 value was obtained with the non-cyclized intermediate.


2019 ◽  
Vol 179 ◽  
pp. 694-706 ◽  
Author(s):  
Yulia A. Volkova ◽  
Andrey S. Kozlov ◽  
Marya K. Kolokolova ◽  
Denis Y. Uvarov ◽  
Sergey A. Gorbatov ◽  
...  

ChemInform ◽  
2005 ◽  
Vol 36 (52) ◽  
Author(s):  
Laurent Brault ◽  
Evelyne Migianu ◽  
Adrien Neguesque ◽  
Eric Battaglia ◽  
Denyse Bagrel ◽  
...  

2018 ◽  
Vol 47 (35) ◽  
pp. 12197-12208 ◽  
Author(s):  
Jitka Pracharova ◽  
Vojtech Novohradsky ◽  
Hana Kostrhunova ◽  
Pavel Štarha ◽  
Zdeněk Trávníček ◽  
...  

A half-sandwich Os(ii) bathophenanthroline complex is a potent agent against highly progressive, poorly treatable triple-negative breast cancer cells.


Sign in / Sign up

Export Citation Format

Share Document